These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 6254859

  • 21. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
    Shi LH, Luo F, Woodward DJ, Chang JY.
    Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
    [Abstract] [Full Text] [Related]

  • 22. Essential factors in the kinetic analysis of RNA synthesis in HeLa cells.
    Puckett L, Darnell JE.
    J Cell Physiol; 1977 Mar; 90(3):521-34. PubMed ID: 853064
    [Abstract] [Full Text] [Related]

  • 23. The effect of delta-9-tetrahydrocannabinol on arachidonic acid metabolism in human peripheral blood mononuclear cells.
    Diaz S, Specter S, Vanderhoek JY, Coffey RG.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1289-96. PubMed ID: 8138942
    [Abstract] [Full Text] [Related]

  • 24. Lethal effect of adriamycin on the division cycle of HeLa cells.
    Kim SH, Kim JH.
    Cancer Res; 1972 Feb; 32(2):323-5. PubMed ID: 5058189
    [No Abstract] [Full Text] [Related]

  • 25. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.
    Lu T, Newton C, Perkins I, Friedman H, Klein TW.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):170-7. PubMed ID: 16443217
    [Abstract] [Full Text] [Related]

  • 26. Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes.
    Bloom AS.
    J Pharmacol Exp Ther; 1982 Apr 17; 221(1):97-103. PubMed ID: 6278139
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. delta 9-Tetrahydrocannabinol selectively inhibits macrophage costimulatory activity and down-regulates heat-stable antigen expression.
    Clements DJ, Cabral GA, McCoy KL.
    J Pharmacol Exp Ther; 1996 Jun 17; 277(3):1315-21. PubMed ID: 8667192
    [Abstract] [Full Text] [Related]

  • 30. Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice.
    Buchweitz JP, Karmaus PW, Harkema JR, Williams KJ, Kaminski NE.
    J Pharmacol Exp Ther; 2007 Nov 17; 323(2):675-83. PubMed ID: 17726158
    [Abstract] [Full Text] [Related]

  • 31. 9-Deazaadenosine. Cytocidal activity and effects on nucleic acids and protein synthesis in human colon carcinoma cells in culture.
    Glazer RI, Hartman KD, Knode MC.
    Mol Pharmacol; 1983 Sep 17; 24(2):309-15. PubMed ID: 6888372
    [Abstract] [Full Text] [Related]

  • 32. Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells.
    von Bueren AO, Schlumpf M, Lichtensteiger W.
    Anticancer Res; 2008 Sep 17; 28(1A):85-9. PubMed ID: 18383828
    [Abstract] [Full Text] [Related]

  • 33. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
    Cox ML, Haller VL, Welch SP.
    Eur J Pharmacol; 2007 Jul 12; 567(1-2):125-30. PubMed ID: 17498686
    [Abstract] [Full Text] [Related]

  • 34. delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages.
    McCoy KL, Gainey D, Cabral GA.
    J Pharmacol Exp Ther; 1995 Jun 12; 273(3):1216-23. PubMed ID: 7791094
    [Abstract] [Full Text] [Related]

  • 35. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
    Cadoni C, Valentini V, Di Chiara G.
    J Neurochem; 2008 Aug 12; 106(4):1586-93. PubMed ID: 18513369
    [Abstract] [Full Text] [Related]

  • 36. Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.
    Takeda S, Yamaori S, Motoya E, Matsunaga T, Kimura T, Yamamoto I, Watanabe K.
    Toxicology; 2008 Mar 12; 245(1-2):141-6. PubMed ID: 18249480
    [Abstract] [Full Text] [Related]

  • 37. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
    Kolb B, Gorny G, Limebeer CL, Parker LA.
    Synapse; 2006 Nov 12; 60(6):429-36. PubMed ID: 16881072
    [Abstract] [Full Text] [Related]

  • 38. delta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits.
    Zhu W, Igarashi T, Friedman H, Klein TW.
    J Pharmacol Exp Ther; 1995 Aug 12; 274(2):1001-7. PubMed ID: 7636714
    [Abstract] [Full Text] [Related]

  • 39. Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis.
    Cohen LS, Studzinski GP.
    J Cell Physiol; 1967 Jun 12; 69(3):331-9. PubMed ID: 4230858
    [No Abstract] [Full Text] [Related]

  • 40. Action of delta 9-tetrahydrocannabinol on cell division and macromolecular synthesis in division-synchronized protozoa.
    McClean DK, Zimmerman AM.
    Pharmacology; 1976 Jun 12; 14(4):307-21. PubMed ID: 819944
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.